Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 13 | 2023 | 1813 | 3.150 |
Why?
|
| Hypoglossal Nerve | 9 | 2023 | 95 | 3.080 |
Why?
|
| Electric Stimulation Therapy | 6 | 2022 | 605 | 2.770 |
Why?
|
| Paranasal Sinuses | 2 | 2017 | 250 | 0.970 |
Why?
|
| Endoscopy | 4 | 2023 | 1785 | 0.830 |
Why?
|
| Snoring | 1 | 2023 | 191 | 0.800 |
Why?
|
| Middle Ear Ventilation | 2 | 2018 | 94 | 0.730 |
Why?
|
| Otitis Media with Effusion | 2 | 2018 | 114 | 0.680 |
Why?
|
| Numismatics | 1 | 2018 | 17 | 0.660 |
Why?
|
| Epistaxis | 1 | 2019 | 111 | 0.640 |
Why?
|
| Oximetry | 1 | 2020 | 471 | 0.600 |
Why?
|
| Mastoiditis | 1 | 2016 | 34 | 0.580 |
Why?
|
| Mastoid | 1 | 2016 | 92 | 0.570 |
Why?
|
| Neck Dissection | 1 | 2018 | 197 | 0.560 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2017 | 116 | 0.560 |
Why?
|
| Parotid Neoplasms | 1 | 2018 | 155 | 0.560 |
Why?
|
| Airway Obstruction | 1 | 2021 | 664 | 0.530 |
Why?
|
| Perineum | 1 | 2017 | 211 | 0.520 |
Why?
|
| Facial Nerve | 1 | 2018 | 271 | 0.520 |
Why?
|
| Ear Auricle | 1 | 2015 | 32 | 0.520 |
Why?
|
| Otitis Media | 1 | 2017 | 277 | 0.510 |
Why?
|
| Skull Base | 1 | 2018 | 306 | 0.510 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2022 | 944 | 0.490 |
Why?
|
| Ear Neoplasms | 1 | 2015 | 117 | 0.490 |
Why?
|
| Foreign Bodies | 1 | 2018 | 399 | 0.470 |
Why?
|
| Facial Paralysis | 1 | 2018 | 338 | 0.460 |
Why?
|
| Polysomnography | 5 | 2023 | 1776 | 0.460 |
Why?
|
| Community-Acquired Infections | 1 | 2017 | 465 | 0.450 |
Why?
|
| Income | 1 | 2022 | 1913 | 0.450 |
Why?
|
| Head and Neck Neoplasms | 2 | 2017 | 2734 | 0.440 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.420 |
Why?
|
| Esophagus | 1 | 2018 | 1019 | 0.420 |
Why?
|
| Sinusitis | 4 | 2016 | 923 | 0.420 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2022 | 1094 | 0.420 |
Why?
|
| Neck | 1 | 2016 | 697 | 0.400 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2017 | 4034 | 0.390 |
Why?
|
| Head | 1 | 2016 | 880 | 0.370 |
Why?
|
| Sleep | 6 | 2023 | 4623 | 0.350 |
Why?
|
| Intensive Care Units | 3 | 2017 | 3679 | 0.340 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 1392 | 0.330 |
Why?
|
| Mortality | 1 | 2020 | 2864 | 0.330 |
Why?
|
| Health Expenditures | 1 | 2021 | 2348 | 0.330 |
Why?
|
| Reoperation | 1 | 2017 | 4201 | 0.310 |
Why?
|
| Postoperative Complications | 2 | 2019 | 15295 | 0.270 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2016 | 152 | 0.270 |
Why?
|
| Pneumonia | 1 | 2017 | 2133 | 0.260 |
Why?
|
| Pennsylvania | 2 | 2016 | 613 | 0.260 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1378 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 20129 | 0.250 |
Why?
|
| Oropharynx | 2 | 2023 | 127 | 0.240 |
Why?
|
| Middle Aged | 16 | 2022 | 213383 | 0.230 |
Why?
|
| Aryldialkylphosphatase | 1 | 2022 | 63 | 0.220 |
Why?
|
| Female | 23 | 2022 | 380194 | 0.220 |
Why?
|
| Male | 23 | 2023 | 350118 | 0.210 |
Why?
|
| Humans | 38 | 2023 | 744343 | 0.210 |
Why?
|
| Adult | 17 | 2023 | 214055 | 0.190 |
Why?
|
| Preoperative Period | 2 | 2021 | 549 | 0.190 |
Why?
|
| Palate | 1 | 2021 | 123 | 0.190 |
Why?
|
| Implantable Neurostimulators | 1 | 2021 | 77 | 0.180 |
Why?
|
| Models, Biological | 1 | 2017 | 9583 | 0.180 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 264 | 0.180 |
Why?
|
| Retrospective Studies | 9 | 2021 | 77449 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 35421 | 0.170 |
Why?
|
| Endopeptidases | 1 | 2023 | 772 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 3616 | 0.170 |
Why?
|
| Aged | 10 | 2022 | 163280 | 0.160 |
Why?
|
| Intubation, Intratracheal | 2 | 2016 | 1364 | 0.160 |
Why?
|
| Immunization | 1 | 2023 | 1256 | 0.160 |
Why?
|
| Recurrence | 3 | 2019 | 8340 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 57776 | 0.160 |
Why?
|
| Certification | 1 | 2021 | 424 | 0.150 |
Why?
|
| Prospective Studies | 6 | 2023 | 53288 | 0.150 |
Why?
|
| Tongue | 1 | 2021 | 406 | 0.150 |
Why?
|
| Treatment Outcome | 7 | 2023 | 63114 | 0.150 |
Why?
|
| Nasal Polyps | 3 | 2013 | 360 | 0.150 |
Why?
|
| Prevalence | 3 | 2020 | 15226 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2022 | 1681 | 0.140 |
Why?
|
| Demography | 1 | 2021 | 1656 | 0.140 |
Why?
|
| Employment | 1 | 2022 | 1132 | 0.130 |
Why?
|
| Young Adult | 6 | 2020 | 56430 | 0.130 |
Why?
|
| Neurites | 1 | 2017 | 388 | 0.120 |
Why?
|
| Thyroid Nodule | 1 | 2022 | 750 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2018 | 1590 | 0.120 |
Why?
|
| Ear, Middle | 1 | 2016 | 334 | 0.120 |
Why?
|
| Incidence | 3 | 2017 | 20947 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8642 | 0.120 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 519 | 0.120 |
Why?
|
| Otolaryngology | 1 | 2021 | 645 | 0.120 |
Why?
|
| B-Lymphocytes | 2 | 2023 | 4665 | 0.120 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2018 | 454 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2020 | 1660 | 0.110 |
Why?
|
| Adolescent | 7 | 2020 | 85781 | 0.110 |
Why?
|
| United States | 5 | 2022 | 69872 | 0.110 |
Why?
|
| Length of Stay | 2 | 2016 | 6309 | 0.110 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15540 | 0.110 |
Why?
|
| Counseling | 1 | 2021 | 1523 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 1162 | 0.110 |
Why?
|
| Infant | 4 | 2018 | 35136 | 0.110 |
Why?
|
| Observer Variation | 1 | 2018 | 2593 | 0.100 |
Why?
|
| Radiology, Interventional | 1 | 2016 | 460 | 0.100 |
Why?
|
| Child, Preschool | 4 | 2018 | 41006 | 0.100 |
Why?
|
| Age Factors | 3 | 2018 | 18370 | 0.100 |
Why?
|
| Risk Factors | 5 | 2023 | 72290 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3474 | 0.100 |
Why?
|
| Vaccination | 1 | 2023 | 3278 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 29063 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2017 | 3689 | 0.090 |
Why?
|
| Asthma, Aspirin-Induced | 1 | 2013 | 182 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2699 | 0.090 |
Why?
|
| Interleukin-9 | 1 | 2009 | 63 | 0.080 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 2282 | 0.080 |
Why?
|
| Patient Selection | 1 | 2020 | 4215 | 0.080 |
Why?
|
| Eosinophils | 1 | 2013 | 955 | 0.080 |
Why?
|
| Rhinitis | 2 | 2013 | 691 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2021 | 3209 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2018 | 3420 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3022 | 0.080 |
Why?
|
| Child | 5 | 2022 | 77709 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2020 | 9849 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 6895 | 0.070 |
Why?
|
| Radiography | 1 | 2018 | 7023 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2011 | 541 | 0.070 |
Why?
|
| Acute Disease | 1 | 2017 | 7149 | 0.070 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2013 | 570 | 0.070 |
Why?
|
| Comorbidity | 1 | 2020 | 10388 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12354 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2008 | 767 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2013 | 3206 | 0.060 |
Why?
|
| Critical Care | 1 | 2017 | 2647 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 2007 | 0.060 |
Why?
|
| Palate, Hard | 1 | 2023 | 57 | 0.060 |
Why?
|
| Survival Rate | 1 | 2018 | 12788 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5319 | 0.060 |
Why?
|
| Palate, Soft | 1 | 2023 | 96 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2018 | 3749 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14722 | 0.060 |
Why?
|
| Biopsy | 1 | 2015 | 6756 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12245 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 12720 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2008 | 1200 | 0.050 |
Why?
|
| Decision Making | 1 | 2016 | 3887 | 0.050 |
Why?
|
| Aspirin | 1 | 2013 | 3282 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2009 | 2499 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16689 | 0.050 |
Why?
|
| Germinal Center | 1 | 2023 | 377 | 0.050 |
Why?
|
| Cytokines | 2 | 2013 | 7322 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2023 | 476 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12959 | 0.040 |
Why?
|
| Specialty Boards | 1 | 2021 | 227 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25043 | 0.040 |
Why?
|
| Monocytes | 1 | 2008 | 2596 | 0.040 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2023 | 546 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4751 | 0.040 |
Why?
|
| Antigens | 1 | 2023 | 1466 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 40075 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 4386 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 12804 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 25625 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 7722 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 81183 | 0.030 |
Why?
|
| Parotid Gland | 1 | 2013 | 168 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 2043 | 0.030 |
Why?
|
| Leukotrienes | 1 | 2013 | 255 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 12072 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 290 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 10180 | 0.020 |
Why?
|
| Cough | 1 | 2013 | 555 | 0.020 |
Why?
|
| Animals | 2 | 2023 | 168757 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2013 | 441 | 0.020 |
Why?
|
| Cysteine | 1 | 2013 | 874 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 15519 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2013 | 1842 | 0.020 |
Why?
|
| Immunomagnetic Separation | 1 | 2008 | 80 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2009 | 743 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5867 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2013 | 1261 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 1641 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2013 | 9146 | 0.020 |
Why?
|
| Affect | 1 | 2013 | 1476 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2011 | 13033 | 0.020 |
Why?
|
| Sex Factors | 1 | 2018 | 10397 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 4982 | 0.010 |
Why?
|
| Mast Cells | 1 | 2011 | 1544 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7279 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6622 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4328 | 0.010 |
Why?
|
| Alleles | 1 | 2009 | 6933 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11366 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29786 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23338 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5524 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13284 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 40561 | 0.010 |
Why?
|
| Asthma | 1 | 2013 | 6011 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 21746 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 19229 | 0.010 |
Why?
|
Concepts
(196)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_